Evidence map›Paper›PMID 34026465›Full record

ReviewPreventive medicine reports2021

Interruption of cancer screening services due to COVID-19 pandemic: lessons from previous disasters.

Douglas M Puricelli Perin, Tess Christensen, Andrea Burón, Jennifer S Haas, Aruna Kamineni, Nora Pashayan, Linda Rabeneck, Robert Smith, Miriam Elfström, Mireille J M Broeders and 1 more

Open access · goldAbstract readReview
In one paragraph

Review in Preventive medicine reports, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
1.6field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 24 citations in OpenAlex.

  1. Impacts of a Public Health Emergency on Cancer Testing Rates, Follow-up, and Cancer Diagnosis: An Evaluation of the COVID-19 Pandemic.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 9 institutions in 6 countries.

Douglas M Puricelli PerinClinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Tess ChristensenRadboud university medical center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands.
Andrea BurónIMIM (Hospital Del Mar Medical Research Institute), Barcelona, Spain.
Jennifer S HaasDivision of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts.
Aruna KamineniKaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
Nora PashayanDepartment of Applied Health Research, Institute of Epidemiology and Healthcare, University College London, London, UK.
Linda RabeneckPrevention and Cancer Control, Ontario Health (Cancer Care Ontario), Toronto, Ontario, Canada.
Robert SmithPrevention and Early Detection Department, American Cancer Society, Atlanta, Georgia.
Miriam ElfströmDepartment of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.
Mireille J M BroedersRadboud university medical center, Radboud Institute for Health Sciences, Nijmegen, the Netherlands.
International Cancer Screening Network ICSN
Radboud University Nijmegen · NLAmerican Cancer Society · USCancer Care Ontario · CAFrederick National Laboratory for Cancer Research · USHospital Del Mar · ESKaiser Permanente Washington Health Research Institute · USMassachusetts General Hospital · USRegion Västra Götaland · SEUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo review the scientific literature seeking lessons for the COVID-19 era that could be learned from previous health services interruptions that affected the delivery of cancer screening services.

methodsA systematic search was conducted up to April 17, 2020, with no restrictions on language or dates and resulted in 385 articles. Two researchers independently assessed the list and discussed any disagreements. Once a consensus was achieved for each paper, those selected were included in the review.

resultsEleven articles were included. Three studies were based in Japan, two in the United States, one in South Korea, one in Denmark, and the remaining four offered a global perspective on interruptions in health services due to natural or human-caused disasters. No articles covered an interruption due to a pandemic. The main themes identified in the reviewed studies were coordination, communication, resource availability and patient follow-up.

conclusionLessons learned applied to the context of COVID-19 are that coordination involving partners across the health sector is essential to optimize resources and resume services, making them more resilient while preparing for future interruptions. Communication with the general population about how COVID-19 has affected cancer screening, measures taken to mitigate it and safely re-establish screening services is recommended. Use of mobile health systems to reach patients who are not accessing services and the application of resource-stratified guidelines are important considerations. More research is needed to explore best strategies for suspending, resuming and sustaining cancer screening programs, and preparedness for future disruptions, adapted to diverse health care systems.

Indexed as

Cancer screening programCOVID-19Early detection of cancerHealth services

Identifiers

PMID34026465
PMCPMC8126519
OpenAlexW3162626243

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.